An untargeted metabolomics approach to characterize short-term and long-term metabolic changes after bariatric surgery

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Narath, Sophie H ^a   Mautner, Selma I ^a,b,e   Svehlikova, Eva ^b   Schultes, Bernd ^d   Pieber, Thomas R ^a,b,e   Sinner, Frank M ^a,b   Gander, Edgar ^a   Libiseller, Gunnar ^a   Schimek, Michael G ^c   Sourij, Harald ^b,e   Magnes, Christoph ^a  

^a JOANNEUM RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d Interdisciplinary Obesity Center eSwiss Medical and Surgical Center   (Switzerland)

^e Centre for Biomarker Research in Medicine (CBmed)   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; BRANCHED CHAIN AMINO ACID; CARNITINE; CHOLINE; CREATININE; DRUG METABOLITE; GLUTAMINE; GLYCINE; INDICAN; ISOBUTYRIC ACID; ISOLEUCINE; LEUCINE; LYSINE; ORNITHINE; PANTOTHENIC ACID; PENTOSE; PHENYLALANINE; PHOSPHATIDYLCHOLINE; PYROGLUTAMIC ACID; SARCOSINE; THREONINE; TRIMETHYLAMINE OXIDE; TRYPTOPHAN; TYROSINE; URACIL; URIDINE; VALINE;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRIC BYPASS SURGERY; HOSPITAL DISCHARGE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RANDOM FOREST; REMISSION; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; AUSTRIA; CLINICAL TRIAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; PROCEDURES; SWITZERLAND;

ADULT; AUSTRIA; BARIATRIC SURGERY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; SWITZERLAND;

EID: 84990844034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161425     Document Type: Article

References (88)

1. WHO | Obesity and overweight [Internet]. World Health Organization; 2015. Available: http://www.who.int/mediacentre/factsheets/fs311/en/
2. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. American Medical Association; 2012; 307: 56-65. Available: http://jama.jamanetwork.com/article.aspx?articleid=1103994
3. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. American Medical Association; 2014; 311: 2297-304. doi: 10.1001/jama.2014.5988
4. Courcoulas AP, Yanovski SZ, Bonds D, Eggerman TL, Horlick M, Staten MA, et al. Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium. JAMA Surg. American Medical Association; 2014; 149:1323-9. Available: http://archsurg.jamanetwork.com/article.aspx?articleid=1909805&guestaccesskey=b00c2d54-fd0d-4b14-914c-36ca80a2205c
5. Goldfine AB, Patti ME. Diabetes improvement following Roux-en-Y gastric bypass: understanding dynamic changes in insulin secretion and action. Diabetes. 2014; 63:1454-6. doi: 10.2337/db13-1918 PMID: 24757197
6. Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med. 2010; 77: 468-76. Available: http://www.ccjm.org/content/77/7/468.long doi: 10.3949/ccjm.77a.09135 PMID: 20601620
7. Poirier P, Cornier M-A, Mazzone T, Stiles S, Cummings S, Klein S, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011; 123:1683-701. Available: http://www.ncbi.nlm.nih.gov/pubmed/21403092 doi:10.1161/CIR.0b013e3182149099 PMID:21403092
8. Vest AR, Heneghan HM, Schauer PR, Young JB. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013; 127: 945-59. Available: http://www.ncbi.nlm.nih.gov/pubmed/23439447 doi: 10.1161/CIRCULATIONAHA.112.103275 PMID: 23439447
9. Stewart B and WCP(eds.). IA for Ron CW. World Cancer Report 2014. 2014; Available: http://www.thehealthwell.info/node/725845
10. Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, et al. Obesity-related cardiovascular riskfactors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010; 163: 735-45. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2950661&tool=pmcentrez&rendertype=abstractdoi:10.1530/EJE-10-0514 PMID: 20798226
11. Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular riskfactors 10 years after bariatric surgery. N Engl J Med. 2004; 351: 2683-93. Available: http://www.ncbi.nlm.nih.gov/pubmed/15616203 PMID: 15616203
12. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-52. Available: http://www.ncbi.nlm.nih.gov/pubmed/17715408 PMID: 17715408
13. Chang S-H, Stoll CRT, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. American Medical Association; 2014; 149: 275-87. Available: http://archsurg.jamanetwork.com/article.aspx?articleid=1790378
14. Benotti P, Wood GC, Winegar DA, Petrick AT, Still CD, Argyropoulos G, et al. Risk Factors Associated With Mortality After Roux-en-Y Gastric Bypass Surgery. Ann Surg. NIH Public Access; 2014; 259:123-130. Available: http://europepmc.org/articles/PMC4075503/?report=abstract
15. Jiménez A, Perea V, Corcelles R, Moizé V, Lacy A, Vidal J. Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects. Obes Surg. 2013; 23: 494-500. Available: http://www.ncbi.nlm.nih.gov/pubmed/23184406 doi: 10.1007/s11695-012-0817-7 PMID: 23184406
16. Bojsen-Møller KN, Dirksen C, Jørgensen NB, Jacobsen SH, Serup AK, Albers PH, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes. American Diabetes Association; 2014; 63: DB-131307. Available:/han/4943-0/diabetes.diabetesjournals.org/content/early/2013/11/13/db13-1307.abstract
17. Dutia R, Brakoniecki K, Bunker P, Paultre F, Homel P, Carpentier AC, et al. Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014; 63:1214-23. doi: 10.2337/db13-1176 PMID: 24296713
18. Dunn WB. Diabetes - the Role of Metabolomics in the Discovery of New Mechanisms and Novel Biomarkers. Curr Cardiovasc Risk Rep. 2012; 7: 25-32. doi: 10.1007/s12170-012-0282-9
19. Magkos F, Bradley D, Schweitzer GG, Finck BN, Eagon JC, Ilkayeva O, et al. Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. Diabetes. 2013; 62: 2757-61. Available: http://diabetes.diabetesjournals.org/content/early/2013/04/17/db13-0185.short doi: 10.2337/db13-0185 PMID: 23610059
20. Newgard C. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012; 15: 606-614. PMID: 22560213
21. Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism. 2013; 62: 961-9. Available: http://www.sciencedirect.com/science/article/pii/S0026049513000085 doi: 10.1016/j.metabol.2013.01.007 PMID: 23375209
22. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes. 2009; 58: 2429-43. doi: 10.2337/db09-0580 PMID: 19875619
23. Suhre K. Metabolic profiling in diabetes. J Endocrinol. 2014; 221: R75-85. doi: 10.1530/JOE-14-0024 PMID: 24868111
24. Krug S, Kastenmüller G, Stückler F, Rist MJ, Skurk T, Sailer M, et al. The dynamic range of the human metabolome revealed by challenges. FASEB J. 2012; 26: 2607-19. doi: 10.1096/fj.11-198093 PMID: 22426117
25. Menni C, Fauman E, Erte I, Perry JRB, Kastenmüller G, Shin S-Y, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013; 62: 4270-6. doi: 10.2337/db13-0570 PMID: 23884885
26. Bergman RN, Stefanovski D, Kim SP. Systems analysis and the prediction and prevention of Type 2 diabetes mellitus. Curr Opin Biotechnol. 2014; 28C: 165-170. Available: http://www.sciencedirect.com/science/article/pii/S0958166914001025
27. Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, Gieger C, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 2010; 5: e13953. doi: 10.1371/journal.pone.0013953 PMID: 21085649
28. Laferrère B, Reilly D, Arias S. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med. 2011; 3.
29. Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia. 2012; 55: 321-30. doi: 10.1007/s00125-011-2356-5 PMID: 22065088
30. Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem. 2012; 58: 139-47. Available: http://www.clinchem.org/content/58/1/139.short doi: 10.1373/clinchem.2011.169573 PMID: 22110018
31. Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014; 2: 65-75. Available: http://www.sciencedirect.com/science/article/pii/S2213858713701438 doi: 10.1016/S2213-8587(13)70143 - PMID: 24622670
32. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. Elsevier Ltd; 2012; 379: 2300-11. doi: 10.1016/S0140-6736(12)60401-2
33. Dixon JB, Blazeby JM. Quality of life after bariatric surgery. Lancet Diabetes Endocrinol. 2014; 2:100-2. Available: http://www.thelancet.com/journals/a/article/PIIS2213-8587(14)70021-X/fulltext doi: 10.1016/S2213-8587(14)70021-X PMID: 24622704
34. Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot J-L, Poitou C, et al. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One. 2009; 4: e7905. doi: 10.1371/journal.pone.0007905 PMID: 19936240
35. Friedrich N, Budde K, Wolf T, Jungnickel A, Grotevendt A, Dressler M, et al. Short-term changes of the urine metabolome after bariatric surgery. OMICS. 2012; 16: 612-20. Available: http://www.ncbi.nlm.nih.gov/pubmed/23095112 doi: 10.1089/omi.2012.0066 PMID: 23095112
36. Arora T, Velagapudi V, Pournaras DJ, Welbourn R, le Roux CW, Orešić M, et al. Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission. PLoS One. Public Library of Science; 2015; 10: e0126401. Available: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126401
37. Svehlikova E, Tuca A, Hoeller V, Obermayer-Pietsch B, Freisinger O, Tadler F, et al. Restoration of beta cell function in severely obese type 2 diabetic patients ater gastric bypass surgery is accompanied by improved insulin processing. DIABETOLOGIA. 2014. pp. S59-S59.
38. Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. Nature Publishing Group; 2012; 7: 872-881. doi: 10.1038/nprot.2012.024
39. Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, Rabinowitz JD. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. J Chromatogr A. 2006; 1125: 76-88. doi: 10.1016/j.chroma.2006.05.019 PMID: 16759663
40. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin Ca, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. Springer; 2007; 3: 211-221. Available: http://www.springerlink.com/index/10.1007/s11306-007-0082-2
41. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007; 35: D521-6. doi: 10.1093/nar/gkl923 PMID: 17202168
42. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009; 37: D603-10. doi: 10.1093/nar/gkn810 PMID: 18953024
43. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res. 2013; 41: D801-7. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3531200&tool=pmcentrez&rendertype=abstract doi: 10.1093/nar/gks1065 PMID: 23161693
44. Smith Ca, O'Maille G, Want EJ, Qin C, Trauger S a, Brandon TR, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005; 27: 747-751. PMID: 16404815
45. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000; 28: 27-30. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=102409&tool=pmcentrez&rendertype=abstract PMID: 10592173
46. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res. 2014; 42:199-205. doi: 10.1093/nar/gkt1076
47. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and Identification. Anal Chem. American Chemical Society; 2006; 78: 779-787. doi: 10.1021/ac051437y
48. Smith ACA, Tauten-R, Neumann S, Ben-P, Conley C. Package "xcms." 2014
49. Libiseller G, Dvorzak M, Kleb U, Gander E, Eisenberg T, Madeo F, et al. IPO: a tool for automated optimization of XCMS parameters. BMC Bioinformatics. 2015; 16:118. doi: 10.1186/s12859-015-0562-8 PMID: 25888443
50. Koenker R. Package "quantreg" [Internet]. 2013 [cited 19 Feb 2014]. Available: http://cran.r-project.org/web/packages/quantreg/quantreg.pdf 23888591
51. Koenker R. Quantile Regression (Econometric Society Monographs) [Internet]. Cambridge University Press; 2005. Available: http://www.amazon.com/Quantile-Regression-Econometric-Society-Monographs/dp/0521608279
52. Saccenti E, Hoefsloot HCJ, Smilde AK, Westerhuis JA, Hendriks MMWB. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics. 2013; Available: http://link.springer.com/10.1007/s11306-013-0598-6
53. Breiman LEO. Random Forests. Mach Learn. Kluwer Academic Publishers; 2001; 45: 5-32. Available: http://link.springer.com/article/10.1023/A:1010933404324
54. Liaw A, Wiener M. Classification and Regression by randomForest. R News. 2002; 2:18-22.
55. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc. 1995; 57: 289-300.
56. Tang WHW, Wang Z, Levison BS, Koeth Ra, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368:1575-84. doi: 10.1056/NEJMoa1109400 PMID: 23614584
57. Wurtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, et al. Metabolite Profiling and Cardiovascular Event Risk: A Prospective Study of Three Population-Based Cohorts. Circulation. 2015; CIRCULATIONAHA.114.013116-. doi: 10.1161/CIRCULATIONAHA.114.013116
58. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. Elsevier Ltd; 2009; 9: 311-26. doi: 10.1016/j.cmet.2009.02.002
59. Walford G, Davis J, Warner S, Ackerman RJ, Billings LK, Chamarthi B, et al. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism. Elsevier Inc.; 2013; 62:1772-8. doi: 10.1016/j.metabol.2013.07.003
60. Nicoletti C Ferreira, Morandi Junqueira-Franco MV, Dos Santos JE, Marchini J Sergio, Junior WS, Nonino CB. Protein and amino acid status before and after bariatric surgery: A 12-month follow-up study. Surg Obes Relat Dis. Elsevier; 2013; 9:1008-12. Available: http://www.soard.org/article/S1550-7289(13)00231-1/abstract
61. Hanzu FA, Vinaixa M, Papageorgiou A, Párrizas M, Correig X, Delgado S, et al. Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: an untargeted metabolomic approach. Obesity (Silver Spring). 2014; 22: 698-704. doi: 10.1002/oby.20541
62. Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, et al. Metabolite profiles during oral glucose challenge. Diabetes. 2013; 62: 2689-98. doi: 10.2337/db12-0754 PMID: 23382451
63. Wang-sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et al. Novel biomarkers for pre-diabetes identified by metabolomics. 2012; doi: 10.1038/msb.2012.43
64. Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013; 62: 639-48. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3554384&tool=pmcentrez&rendertype=abstract doi: 10.2337/db12-0495 PMID: 23043162
65. Walford G, Porneala BC, Dauriz M, Vassy JL, Cheng S, Rhee EP, et al. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care. 2014; 37: 2508-14. doi: 10.2337/dc14-0560 PMID: 24947790
66. Ernährungsmedizin DA-G (D) DGfür PM und PDG für. S3-Leitlinie: Chirurgie der Adipositas. In: Evaluation [Internet]. 2010 pp. 1-59. Available: http://www.adipositas-gesellschaft.de/fileadmin/PDF/Leitlinien/ADIP-6-2010.pdf
67. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010; 95: 4823-4843. doi: 10.1210/jc.2009-2128 PMID: 21051578
68. Arora P. Metabolomics yield a novel biomarker for predicting diabetes mellitus risk in humans. CircCar-diovasc Genet. 2014; 7: 95-6. Available: http://circgenetics.ahajournals.org/content/7/1/95.short doi: 10.1161/CIRCGENETICS.114.000528 PMID: 24550433
69. Sigruener A, Kleber ME, Heimerl S, Liebisch G, Schmitz G, Maerz W. Glycerophospholipid and sphin-golipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. PLoS One. 2014; 9: e85724. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3895004&tool=pmcentrez&rendertype=abstract doi: 10.1371/journal.pone.0085724 PMID: 24465667
70. Saccenti E, Suarez-Diez M, Luchinat C, Santucci C, Tenori L. Probabilistic networks of blood metabolites in healthy subjects as indicators of latent cardiovascular risk. J Proteome Res. 2015; 14:1101-11. doi: 10.1021/pr501075r PMID: 25428344
71. Ashrafian H, Li J V, Spagou K, Harling L, Masson P, Darzi A, et al. Bariatric surgery modulates circulating and cardiac metabolites. J Proteome Res. 2014; 13: 570-80. doi: 10.1021/pr400748f PMID: 24279706
72. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. Nature Publishing Group; 2011; 472: 57-63. doi:10.1038/nature09922
73. Wang Z, Tang WHW, Buffa JA, Fu X, Britt EB, Koeth RA, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J. 2014; 35: 904-10. Available: http://eurheartj.oxfordjournals.org/content/early/2014/02/03/eurheartj.ehu002.short doi: 10.1093/eurheartj/ehu002 PMID: 24497336
74. Panunzi S, Carlsson L, De Gaetano A, Peltonen M, Rice T, Sjöström L, et al. Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery. Diabetes Care. 2016; 39:166-74. Available: http://care.diabetesjournals.org/content/early/2015/11/29/dc15-0575 doi: 10.2337/dc15-0575 PMID: 26628418
75. Klein MS, Shearer J. Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application. J Diabetes Res. 2016;2016.
76. Dunn WB, Wilson ID, Nicholls AW, Broadhurst D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis. Future Science Ltd London, UK; 2012; 4: 2249-64. doi: 10.4155/bio.12.204
77. Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, et al. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics. 2014; 11: 9-26. doi: 10.1007/s11306-014-0707-1 PMID: 25598764
78. Wang S-Y, Kuo C-H, Tseng YJ. Batch Normalizer: A Fast Total Abundance Regression Calibration Method to Simultaneously Adjust Batch and Injection Order Effects in Liquid Chromatography/Time-of-Flight Mass Spectrometry-Based Metabolomics Data and Comparison with Current Calibration Met. Anal Chem. American Chemical Society; 2013; 85:1037-46. Available: http://dx.doi.org/10.1021/ac302877x
79. Lee J, Park J, Lim M, Seong SJ, Seo JJ, Park SM, et al. Quantile normalization approach for liquid chromatography-mass spectrometry-based metabolomic data from healthy human volunteers. Anal Sci. 2012; 28: 801-5. Available: http://www.ncbi.nlm.nih.gov/pubmed/22878636 PMID: 22878636
80. Liu X, Zhang Z, Sousa PFM, Chen C, Ouyang M, Wei Y, et al. Selective iteratively reweighted quantile regression for baseline correction. Anal Bioanal Chem. 2014; 406:1985-98. Available: http://www.ncbi.nlm.nih.gov/pubmed/24429977 doi: 10.1007/s00216-013-7610-x PMID: 24429977
81. Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M. Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. CurrBioinform. 2012; 7: 96-108. doi: 10.2174/157489312799304431 PMID:22438836
82. Touw Wouter, Bayjanov JR, Overmars L, Backus L, Boekhorst J, Wels M. Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle? Brief Bioinform. 2012; doi: 10.1093/bib/bbs034
83. Chen T, Cao Y, Zhang Y, Liu J, Bao Y, Wang C, et al. Random forest in clinical metabolomics for phenotypic discrimination and biomarker selection. Evid Based Complement Alternat Med. 2013; 2013: 298183. doi: 10.1155/2013/298183 PMID: 23573122
84. Li S, Harner EJ, Adjeroh D a. Random KNN feature selection - a fast and stable alternative to Random Forests. BMC Bioinformatics. BioMed Central Ltd; 2011; 12: 450. doi: 10.1186/1471-2105-12-450
85. Milburn MV, Lawton Ka. Application of metabolomics to diagnosis of insulin resistance. Annu Rev Med. 2013; 64: 291-305. doi: 10.1146/annurev-med-061511-134747 PMID: 23327524
86. Ai F-F, Bin J, Zhang Z, Huang J, Wang J, Liang Y, et al. Application of random forests to select premium quality vegetable oils by their fatty acid composition. Food Chem. 2014; 143: 472-8. Available: http://www.sciencedirect.com/science/article/pii/S0308814613010820 doi: 10.1016/j.foodchem.2013.08.013 PMID: 24054269
87. Lin X, Wang Q, Yin P, Tang L, Tan Y, Li H, et al. A method for handling metabonomics data from liquid chromatography/mass spectrometry: combinational use of support vector machine recursive feature elimination, genetic algorithm and random forest for feature selection. Metabolomics. 2011; 7: 549-558. doi: 10.1007/s11306-011-0274-7
88. Strobl C, Boulesteix A-L, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics. 2008; 9: 307. Available: http://www.biomedcentral.com/1471-2105/9/307 doi: 10.1186/1471-2105-9-307 PMID: 18620558